Gideon Ho

An A STAR National Science scholar (fellowship), Gideon has been involved in bio-imaging development and research for the past 13 years, with added experience in project and operations management. He has four filed patents, and published multiple journal articles in medical imaging, lasers and optics.

In August 2010, Gideon co-founded HistoIndex as a spin-off from the Institute of Bioengineering and Nanotechnology (IBN) at the Agency for Science, Technology and Research (A STAR), to develop and commercialize the world’s first fully automated, quantitative, stain-free imaging system and gain a first-mover advantage in global healthcare markets. As the CEO, Gideon sets the company’s overall corporate, commercial and marketing strategies to drive business growth and market shares.

With his leadership, the laser-based medical imaging systems – Genesis® and Laennec® – were successfully developed by the company and are currently being used for academic, clinical and commercial research in major universities, hospitals and contract reference facilities around the world, including the United States, Europe, China, Australia and Singapore.